Vanina de Verneuil, EVP and General Counsel at Vir Biotechnology, Inc. (VIR), sold 76 shares at $8.22 ($625) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Open-market sale of $625 VIR by EVP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2025-11-07 | $12K | — | Filing → |
| VIR | SELL | 2025-11-04 | $8K | — | Filing → |
| VIR | SELL | 2025-02-27 | $135K | — | Filing → |